National and Kapodistrian University of Athens
Επίδραση μεταλλαγμένων μορφών p53 πρωτεΐνης στη διαταραχή του παλίνδρομου αρνητικού μηχανισμού ανάδρασης P53-MDM2 στον καρκίνο του πνεύμονα
Abstract
dc:descriptionAim: P53 and MDM2 constitute a negative feedback loop. The coexistence of these two molecules in sarcomas and lung carcinomas has been associated with poor prognosis. In the present PhD study the status of p53 and MDM2 was evaluated in a series of lung carcinomas, and the role of p53 mutants was examined, especially, in the cases where a deregulation of the above mentioned feedback loop was found. Material and Methods: The sample comprised 21 squamous cell carcinomas, 19 adenocarcinomas and 10 small cell carcinomas of the lung. Evaluation of p53 and MDM2 protein status was based on immunohistochemical and Western blot analysis. Moreover, p53 status was examined by mutation analysis (SSCP and Sequencing) and LOH analysis (using Southern blot), whereas MDM2 status was focused on mRNA levels (Northern blot) and gene-amplification (differential PCR). Next, the role of certain p53 mutants, derived from specimens characterized by deregulation in the p53-MDM2 feedback loop, was examined. In detail, certain p53 mutants were examined for their ability i) to bind the p53 responsive element (RE)of the MDM2 gene (Retardation assay) and ii) to transactivate the luciferase reference gene via MDM2-p53RE (side-directed mutagenesis and luciferase assay after transfection of H1299 p53-null cell line). Results: P53 immunopositivity was observed in 28 cases (56%). This was associated with p53 mutation (24 of 28 specimens) and loss of heterozygosity (13 of 16 informative cases) (p<0.0001 και p=0.015, respectively). Protein analysis for MDM2 revealed nuclear immunostaining in 30 (60%) samples, and the existence of three isoforms: p90, p76/74 and p57. The MDM2 overexpression was accompanied by increased mRNA levels and not by gene amplification. Co-existence of p53 and MDM2 was observed in 21 of 28 cases with mutant p53. The results of the binding assay for 12 selected p53 mutants were in accordance with those of the protein analysis. The luciferase assay experiments showed the importance of certain mutations for special biological properties of the p53. Conclusions: Concurrent nuclear immunostaining of p53 and MDM2 was observed in a subset of lung carcinomas. This phenomenon, that was associated with poor differentiation and lymph node invasion, was -in part- a result of the function of special p53 mutants possessing oncogenic properties. In general, it was found that the role of the p53 mutants was depended on the position and the nature of the mutation and the presence of the wild type p53.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2001
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Zacharatos, Panagiotis
- Ζαχαράτος, Παναγιώτης
Subjects
dc:subject × 14- Πρωτεΐνη p53, Ογκοκατασταλτική
- Πρωτεΐνη MDM2
- Καρκίνος πνεύμονα
- Παλίνδρομος αρνητικός μηχανισμός ανάδρασης p53-MDM2
- Μεταλλαγμένες p53 πρωτεΐνες
- p53 proteins
- MDM2 protein
- Lung carcinomas
- p53-MDM2 feedback loop
- p53 mutants
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/20322